Search Results for: Neueste Certified Application Associate - SAP S/4HANA Cloud (public) - Sales Implementation Prüfung pdf - C_S4CS_2208 Prüfung Torrent 🐹 Suchen Sie jetzt auf ⇛ www.itzert.com ⇚ nach ▶ C_S4CS_2208 ◀ und laden Sie es kostenlos herunter 🤷C_S4CS_2208 Examsfragen
Cardiac and Neurological Approaches in ATTR Management
In this ARC TALKS webinar, Dr. Nativi-Nicolau and Dr. Elizabeth Mauricio discussed the decision pathway in management of ATTR amyloidosis from the cardiac and neurological standpoint.
Approaches to Treating Relapsed and Refractory AL Amyloidosis
In this ARC TALKS webinar, Dr. Heather Landau discussed current treatment options for relapsed and refractory AL amyloidosis patients.
Dr. Landau also talked about the current testing methodology used to monitor a patient’s disease status, and the role maintenance therapy may play in the management of relapsed AL amyloidosis.
The Fundamentals of Clinical Trials and Current Advances in Amyloidosis Research
In this ARC Talks Webinar, Dr. Morie Gertz gave a 101 overview of clinical trials, including consideration in how they are designed, and the phases needed for drug development.
Dr. Gertz also discussed current clinical trials that are evaluating the next generation of drugs for the treatment of AL and ATTR amyloidosis.
Join our email list to stay up to date on the latest Amyloidosis news.
In this ARC Talks Webinar, Dr. Morie Gertz gave a 101 overview of clinical trials, including consideration in how they are designed, and the phases needed for drug development. Dr. Gertz also discussed current clinical trials that are evaluating the next generation of drugs for the treatment of AL and ATTR amyloidosis.
Original Presentation Date:
May 25, 2023
Key Webinar Highlights:
0:00 — Introduction
3:10 — Start of Dr. Gertz’s presentation
4:30 — The Necessity of Clinical Trials
13:50 — The Phases of Clinical Trials
23:23 — Definition of An Open Label Extension
24:47 — The Study of Vyndaquel for ATTR-CM Patients
26:18 — The Study of Drug Therapies for ATTR-PN/hATTR patients